Synthesis and synergistic antifungal activities of a pyrazoline based ligand and its copper(II) and nickel(II) complexes with conventional antifungals

Microbial Pathogenesis

Volumn 53, Issue 2, 2012, Pages 66-73

  Ali, Imran ^a   Wani, Waseem A ^a   Khan, Amber ^a   Haque, Ashanul ^a   Ahmad, Aijaz ^a   Saleem, Kishwar ^a   Manzoor, Nikhat ^a  

^a JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

Author keywords

Candida; Disc diffusion assay; FICI and synergism; MICs; Pyrazoline based ligand

Indexed keywords

5 (4 CHLOROPHENYL) 3 PHENYL 4,5 DIHYDRO 1H PYRAZOLE 1 CARBOTHIOAMIDE COPPER COMPLEX; 5 (4 CHLOROPHENYL) 3 PHENYL 4,5 DIHYDRO 1H PYRAZOLE 1 CARBOTHIOAMIDE NICKEL COMPLEX; ACETOPHENONE; AMPHOTERICIN B; ANTIFUNGAL AGENT; BENZALDEHYDE DERIVATIVE; CHALCONE; FLUCONAZOLE; PARA CHLOROBENZALDEHYDE; SODIUM HYDROXIDE; THIOSEMICARBAZIDE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; CYCLIZATION; DISK DIFFUSION; DRUG EFFICACY; DRUG RESEARCH; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; INFRARED SPECTROSCOPY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; ULTRAVIOLET SPECTROSCOPY;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; COPPER; DRUG SYNERGISM; HUMANS; LIGANDS; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; NICKEL; PYRAZOLES;

CANDIDA;

EID: 84862758759     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2012.04.005     Document Type: Article

References (28)

1. Kriengkauykiat J., Ito J.I., Dadwal S.S. Epidemiology and treatment approaches in management of invasive fungal infections. Clin Epidemiol 2011, 3:175-191.
2. Bodey G.P. Fungal infection and fever of unknown origin in neutropenic patients. Am J Med 1986, 80:112-119.
3. Bodey G.P. Candidiasis in cancer patients. Am J Med 1984, 77:13-19.
4. Nguyen M.H., Peacock J.E., Morris A.J., Tanner D.C., Nguyen M.L., Snydman D.R., et al. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med 1996, 100:617-623.
5. Li L., Kashleva H., Dongari-Bagtzoglou A. Cytotoxic and cytokine-inducing properties of Candida glabrata in single and mixed oral infection models. Microb Pathog 2007, 42:138-147.
6. Verduyn Lunel F.M., Meis J.F., Voss A. Nosocomial fungal infections: candidemia. Diagn Microbiol Infect Dis 1999, 34:213-220.
7. Odds F.C., Brown A.J., Gow N.A. Antifungal agents: mechanisms of action. Trends Microbiol 2003, 11:272-279.
8. Gupta A.K., Thomas E. New antifungal agents. Dermatol Clin 2003, 21:565-576.
9. Van den Bossche H., Dromer F., Improvissi I., Lozane-Chiu M., Hex J.H., Sanglard D. Antifungal drug resistance in pathogenic fungi. Med Mycol 1998, 36:119-128.
10. Marui J., Yoshimi A., Hagiwara D., Fujii-Watanabe Y., Oda K., Koike H., et al. Use of the Aspergillus oryzae actin gene promoter in a novel reporter system for exploring antifungal compounds and their target genes. Appl Microbiol Biotechnol 2010, 87:1829-1840.
11. Khokhar N.Z., Altman J.K., Platanias L.C. Emerging roles for mammalian target of rapamycin inhibitors in the treatment of solid tumors and hematological malignancies. Curr Opin Oncol 2011, 23:578-586.
12. Shaaban M.R., Mayhoub A.S., Farag A.M. Recent advances in the therapeutic applications of pyrazolines. Expert Opin Ther Pat 2012, 22:253-291.
13. La Monica G., Ardizzoia G.A. The role of the pyrazolate ligand in building polynuclear transition metal systems. Prog Inorg Chem 1997, 28:151-238.
14. Bekhit A.A., Abdel-Aziem T. Design, synthesis and biological evaluation of some pyrazole derivatives as anti-inflammatory-antimicrobial agents. Bioorg Med Chem 2004, 12:1935-1945.
15. Bekhit A.A., Hymete A., Asfaw H., Bekhit A.D.A. Synthesis and biological evaluation of some pyrazole derivatives as anti-Malarial agents. Arch Pharm 2012, 345:147-154.
16. Onoa G.B., Moreno V., Font-Bardia M., Solans X., Perez J.M., Alonso C. Structural and cytotoxic study of new Pt (II) and Pd (II) complexes with the bi-heterocyclic ligand mepirizole. J Inorg Biochem 1999, 75:205-212.
17. Prabhakaran R., Renukadevi S.V., Karvembu R., Huang R., Mautz J., Huttner G., et al. Structural and biological studies of mononuclear palladium (II) complexes containing N-substituted thiosemicarbazones. Eur J Med Chem 2008, 43:268-273.
18. Shreaz S., Sheikh R.A., Rimple B., Hashmi A.A., Nikhat M., Khan L.A. Anticandidal activity of cinnamaldehyde, its ligand and Ni(II) complex: effect of increase in ring and side chain. Microb Pathog 2010, 49:75-82.
19. Patil S.A., Unkia S.N., Kulkarnia A.D., Naika V.H., Badamib P.S. Co(II), Ni(II) and Cu(II) complexes with coumarin-8-yl Schiff-bases: spectroscopic, in vitro antimicrobial, DNA cleavage and fluorescence studies. Spectrochim Acta A 2011, 79:1128-1136.
20. Manikshete A.H., Sarsamkar S.K., Deodware S.A., Kamble V.N., Asabe M.R. Synthesis, characterization and antimicrobial activity of new cobalt(II), nickel(II) and copper(II) complexes with 2-(2-hydroxy-1, 2-diphenylethylideneamino) benzoic acid. Inorg Chem Commun 2011, 14:618-621.
21. 2 hexadentate Schiff base ligand: synthesis, spectroscopic characterization and efficient antimicrobial activities. Spectrochim Acta A 2010, 77:740-748.
22. Khan A., Ahmad A., Xess I., Khan L.A., Manzoor N. Anticandidal effect of Ocimum sanctum essential oil and its synergy with fluconazole and ketoconazole. Phytomedicine 2010, 17:921-925.
23. Ahmad A., Khan A., Manzoor N., Khan L.A. Evolution of ergosterol biosynthesis inhibitors as fungicidal against Candida. Microb Pathog 2010, 48:35-41.
24. Cantón R.F., Sanderson J.T., Letcher R.J., Bergman A., van den Berg M. Inhibition and induction of aromatase (CYP19) activity by brominated flame retardants in H295R human adrenocortical carcinoma cells. Toxicol Sci 2005, 88:447-455.
25. Krishna C.H., Mahapatra C.M., Dash A.K. 4-5 and 6-coordinate complexes of copper (II) with substituted imidazoles. J Inorg Nucl Chem 1977, 39:1253-1258.
26. Chohan Z.H., Pervez H., Khan K.M., Rauf A., Maharvi G.M., Supuran C.T. Antifungal cobalt(II), copper(II), nickel(II) and zinc(II) complexes of furanyl-, thiophenyl-, pyrrolyl-, salicylyl- and pyridyl-derived cephalexins. J Enzym Inhib Med Chem 2004, 19:85-90.
27. Sharma M., Manoharlal R., Shukla S., Puri N., Prasad T., Ambudkar S.V., et al. Curcumin modulates efflux mediated by yeast ABC multidrug transporters and is synergistic with antifungals. Antimicrob Agents Chemother 2009, 53:3256-3265.
28. Sharma M., Manoharlal R., Negi A.S., Prasad R. Synergistic anticandidal activity of pure polyphenol curcumin I in combination with azoles and polyenes generates reactive oxygen species leading to apoptosis. FEMS Yeast Res 2010, 10:570-578.